BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. IL1A, Coagulation, Influenza, Hippocampus, Personalized medicine, Bleomycin, rs3825942)
Bookmark Forward

QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=FF757BBF2C3F26729F6794DB8781F95F (gene)


Body Atlas

Most Correlated Tissues

  1. Mononuclear cell of peripheral blood
  2. Whole blood
  3. Monocyte of peripheral blood
  4. Myeloid cells of peripheral blood
  5. Basophil of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Disease due to Arenavirus
  2. Bacterial septicemia
  3. Shock
  4. Sepsis due to Gram negative bacteria
  5. Septicemia due to Klebsiella
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Recombinant Fusion Proteins
  2. asperflavin
  3. 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine
  4. phorbolol myristate acetate
  5. Immunoglobulin Fc Fragments
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ZCCHC24
  2. MXD3
  3. EHMT2
  4. BAG3
  5. MUSK
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
  2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
  3. Stability of varicella-zoster virus open reading frame 63.
  4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
  5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=FF757BBF2C3F26729F6794DB8781F95F
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.